Did Cephalon use fake ad-boards?

Share this article:

A whistleblower says Cephalon used CME, “bogus ‘market research surveys' and Advisory Board meetings” to disseminate an off-label message about Treanda to prescribers.

The firm also illegally promoted opioid analgesic Fentora for non-cancer pain, the plaintiff claims, by using its general, rather than oncology, sales force.

The 2009 actions, which boosted costs to government programs, are particularly troubling because, at the time, Cephalon would have been operating under a corporate integrity agreement, signed in 2008, in which it pledged to cease all off-label marketing, and settled off-label marketing charges on three other drugs for $425 ­million.
Share this article:
close

Next Article in Agency Gallery

Email Newsletters

More in Agency Gallery

Agency Business briefs: June 2014

Agency Business briefs: June 2014

News on Publicis, Palio+Ignite, PulseCX, McCann HumanCare and GolinHarris

It's time to replace the FDA, says Newt Gingrich

It's time to replace the FDA, says Newt ...

Former Speaker of the House and presidential candidate Newt Gingrich has declared that it's time to replace FDA

Agency Business briefs: May 2014

Agency Business briefs: May 2014

Newson ID Media, Frontline Medical Communications and ContextMedia